Literature DB >> 22935082

Pro-fibrotic processes in human lung fibroblasts are driven by an autocrine/paracrine endothelinergic system.

A S Ahmedat1, M Warnken, W K Seemann, K Mohr, E Kostenis, U R Juergens, K Racké.   

Abstract

BACKGROUND AND
PURPOSE: Since endothelin (ET) may act as pro-fibrotic mediator, expression and release of ET isoforms, their receptors and potential pro-fibrotic ET effects were studied in human lung fibroblasts. EXPERIMENTAL APPROACH: MRC-5 and primary human lung fibroblasts (phLFb) were cultured. Expression of prepro-ET isoforms was determined by qPCR and release of ET-1 by elisa. ET receptor function was analysed by real-time measurement of dynamic mass redistribution (DMR). Incorporation of [(3) H]-thymidine was determined as measure of proliferation and that of [(3) H]-proline for collagen synthesis. Phospho-p42/44 MAP kinase was determined by Western blot. KEY
RESULTS: ET-1 is the predominant ET in human lung fibroblasts (hLF), and TGF-β caused a further, selective and sustained up-regulation of ET-1 resulting in increased extracellular ET-1 accumulation. hLFb express mRNA encoding ET-A and ET-B receptors. Expression of both receptors was confirmed at protein level. ET-1 induced marked DMR signals, an effect that involved ET-A and ET-B receptors. Stimulatory effects of ET-1 on hLFb proliferation and collagen synthesis were mediated exclusively via ET-A receptors. ET-1, again via ET-A receptors, induced rapid activation of ERK MAPK, shown to be a crucial cellular signal in ET-1-induced collagen synthesis. ET-1-induced activation of ERK and collagen synthesis was, in contrast to corresponding effect of a muscarinic agonist, largely insensitive to pertussis toxin. CONCLUSIONS AND IMPLICATIONS: hLFb are endowed with all elements necessary to build a functional autocrine/paracrine endothelinergic system, which appears to drive pro-fibrotic airway and lung remodelling processes, effects for which only ET-A, but not ET-B receptors appear to be of significance.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22935082      PMCID: PMC3572572          DOI: 10.1111/j.1476-5381.2012.02190.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Endothelin-1-induced bronchoconstriction in asthma.

Authors:  G W Chalmers; S A Little; K R Patel; N C Thomson
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

2.  Muscarinic receptors mediate stimulation of human lung fibroblast proliferation.

Authors:  Sonja Matthiesen; Amit Bahulayan; Susanne Kempkens; Susanne Haag; Margarita Fuhrmann; Christine Stichnote; Uwe R Juergens; Kurt Racké
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-10       Impact factor: 6.914

3.  Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells.

Authors:  Ralf Schröder; Johannes Schmidt; Stefanie Blättermann; Lucas Peters; Nicole Janssen; Manuel Grundmann; Wiebke Seemann; Dorina Kaufel; Nicole Merten; Christel Drewke; Jesus Gomeza; Graeme Milligan; Klaus Mohr; Evi Kostenis
Journal:  Nat Protoc       Date:  2011-10-20       Impact factor: 13.491

4.  A synthetic inhibitor of the mitogen-activated protein kinase cascade.

Authors:  D T Dudley; L Pang; S J Decker; A J Bridges; A R Saltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases.

Authors:  Luca Gallelli; Girolamo Pelaia; Bruno D'Agostino; Giovanni Cuda; Alessandro Vatrella; Donatella Fratto; Vincenza Gioffrè; Umberto Galderisi; Marilisa De Nardo; Claudio Mastruzzo; Elisa Trovato Salinaro; Mauro Maniscalco; Matteo Sofia; Nunzio Crimi; Francesco Rossi; Mario Caputi; Francesco S Costanzo; Rosario Maselli; Serafino A Marsico; Carlo Vancheri
Journal:  J Cell Biochem       Date:  2005-11-01       Impact factor: 4.429

Review 6.  Endothelins and asthma.

Authors:  R G Goldie; P J Henry
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

7.  Effects of bacterial lipopolysaccharides (LPS) and tumour necrosis factor-alpha (TNF alpha) on rat tracheal epithelial cells in culture: morphology, proliferation and induction of nitric oxide (NO) synthase.

Authors:  A Freitag; A Reimann; I Wessler; K Racké
Journal:  Pulm Pharmacol       Date:  1996-06

8.  Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

Authors:  K Ishikawa; M Ihara; K Noguchi; T Mase; N Mino; T Saeki; T Fukuroda; T Fukami; S Ozaki; T Nagase
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Protein kinase C inhibitors decrease endothelin ET(B) receptor mRNA expression and contraction during organ culture of rat mesenteric artery.

Authors:  Erik Uddman; Mikael Adner; Lars Edvinsson
Journal:  Eur J Pharmacol       Date:  2002-10-04       Impact factor: 4.432

10.  Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon.

Authors:  R A Panettieri; R G Goldie; P J Rigby; A J Eszterhas; D W Hay
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more
  10 in total

Review 1.  Cellular Pathways Promoting Pulmonary Vascular Remodeling by Hypoxia.

Authors:  Larissa A Shimoda
Journal:  Physiology (Bethesda)       Date:  2020-07-01

2.  Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model.

Authors:  P Comeglio; S Filippi; E Sarchielli; A Morelli; I Cellai; C Corno; A Pini; L Adorini; G B Vannelli; M Maggi; L Vignozzi
Journal:  J Endocrinol Invest       Date:  2018-06-19       Impact factor: 4.256

Review 3.  Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?

Authors:  Michael Roth
Journal:  Drugs       Date:  2015-01       Impact factor: 9.546

Review 4.  Current Pharmacological Approach to ARDS: The Place of Bosentan.

Authors:  Omer Araz
Journal:  Eurasian J Med       Date:  2020-02

Review 5.  Endothelial-to-mesenchymal transition in systemic sclerosis.

Authors:  P Cipriani; R Giacomelli; P Di Benedetto; P Ruscitti; O Berardicurti; M Vomero; L Navarini; V Dolo
Journal:  Clin Exp Immunol       Date:  2021-04-18       Impact factor: 5.732

6.  Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis.

Authors:  Tinazzi Elisa; Puccetti Antonio; Patuzzo Giuseppe; Barbieri Alessandro; Argentino Giuseppe; Confente Federico; Dolcino Marzia; Beri Ruggero; Marchi Giacomo; Ottria Andrea; Righetti Daniela; Rampudda Mariaelisa; Lunardi Claudio
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

7.  Hypoxia-induced collagen synthesis of human lung fibroblasts by activating the angiotensin system.

Authors:  Shan-Shan Liu; Hao-Yan Wang; Jun-Ming Tang; Xiu-Mei Zhou
Journal:  Int J Mol Sci       Date:  2013-12-10       Impact factor: 5.923

8.  Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-Mediated Airway Relaxation.

Authors:  Maggie Lam; Simon G Royce; Chantal Donovan; Maria Jelinic; Laura J Parry; Chrishan S Samuel; Jane E Bourke
Journal:  Front Pharmacol       Date:  2016-10-27       Impact factor: 5.810

9.  Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.

Authors:  Claudio Corallo; Maurizio Cutolo; Bashar Kahaleh; Gianluca Pecetti; Antonio Montella; Chiara Chirico; Stefano Soldano; Ranuccio Nuti; Nicola Giordano
Journal:  Arthritis Res Ther       Date:  2016-10-06       Impact factor: 5.156

10.  Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.

Authors:  Maurizio Cutolo; Barbara Ruaro; Paola Montagna; Renata Brizzolara; Emanuela Stratta; Amelia Chiara Trombetta; Stefano Scabini; Pier Paolo Tavilla; Aurora Parodi; Claudio Corallo; Nicola Giordano; Sabrina Paolino; Carmen Pizzorni; Alberto Sulli; Vanessa Smith; Stefano Soldano
Journal:  Arthritis Res Ther       Date:  2018-05-02       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.